Gilead Sciences, Inc. (GILD)
129.58
-2.48
(-1.88%)
USD |
NASDAQ |
May 15, 16:00
129.69
+0.11
(+0.08%)
After-Hours: 20:00
Gilead Sciences EPS Diluted (Quarterly) : 1.612 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 3.344 |
| Biogen, Inc. | 2.153 |
| AbbVie, Inc. | 0.3861 |
| Moderna, Inc. | -3.40 |
| Abbott Laboratories | 0.6165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 2.021B |
| Revenue (Quarterly) | 6.984B |
| Total Expenses (Quarterly) | 4.963B |
| Enterprise Value | 173.16B |
| Gross Profit Margin (Quarterly) | 79.31% |
| Profit Margin (Quarterly) | 28.94% |
| Earnings Yield | 5.67% |
| Operating Earnings Yield | 7.41% |
| Normalized Earnings Yield | 5.954 |